Open Journal of Blood Diseases

Open Journal of Blood Diseases

ISSN Print: 2164-3180
ISSN Online: 2164-3199
www.scirp.org/journal/ojbd
E-mail: ojbd@scirp.org
"TET2 Mutations in Ph-Negative-Myeloproliferative Neoplasms: Identification of Three Novel Mutations and Relationship with Clinical and Laboratory Findings"
written by Andrea Patriarca, Donatella Colaizzo, Gianluca Tiscia, Raffaele Spadano, Silvia Di Zacomo, Antonio Spadano, Ida Villanova, Maurizio Margaglione, Elvira Grandone, Alfredo Dragani,
published by Open Journal of Blood Diseases, Vol.3 No.3, 2013
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Systematization of analytical studies of polycythemia vera, essential thrombocythemia and primary myelofibrosis, and a meta-analysis of the frequency of JAK2, CALR and MPL mutations: 2000–2018
BMC cancer, 2019
[2] Systematization of analytical studies of polycythemia vera, essential thrombocythemia and primary myelofibrosis, and a meta-analysis of the frequency of JAK2, CALR …
2019
[3] Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology
Critical Reviews in Oncology/Hematology, 2018
[4] Значение клинических и молекулярно-генетических факторов в стратификации рисков у больных истинной полицитемией
2017
[5] Pro-and Antifibrotic Factors in the Serum of Patients with Chronic Myeloproliferative Disorders
Clinical oncohematology, 2017
[6] Genomic profile of a patient with triple negative essential thrombocythemia, unresponsive to therapy: A case report and literature review
Journal of Advanced Research, 2017
[7] TET2, ASXL1, IDH1, and IDH2 Single Nucleotide Polymorphisms in Turkish Patients with Chronic Myeloproliferative Neoplasms
Turkish Journal of Hematology, 2017
[8] MİYELOPROLİFERATİF NEOPLAZMLARA MOLEKÜLER GENETİK YAKLAŞIM.
Nobel Medicus Journal, 2017
[9] БИОЛОГИЯ МИЕЛОПРОЛИФЕРАТИВНЫХ НОВООБРАЗОВАНИЙ
2016
[10] Biology of Myeloproliferative Malignancies
Clinical oncohematology, 2016
[11] Myeloproliferative neoplasms: Current molecular biology and genetics
Critical reviews in oncology/hematology, 2015
[12] Myeloproliferative Neoplasms Associated with Mutation in JAK2V617F and Tyrosine Kinase Inhibitors as Therapeutic Strate
Research in Molecular Medicine, 2015
[13] Myeloproliferative disorders and its associated mutations
Research in Molecular Medicine, 2014
[14] The relationship between Human Papillomavirus and Epstein-Barr virus infections with breast cancer of Iranian patients
2013
Free SCIRP Newsletters
Copyright © 2006-2021 Scientific Research Publishing Inc. All Rights Reserved.
Top